positions available now

Monthly Archives: February 2016

Dr Greg Pearce – Time to support biosimilars

Dr Greg Pearce, from our Regulatory Services team, has written a follow-up article for Pharma in Focus on biosimilars. Dr Pearce’s first article focussed on the challenges biosimilars pose for the Australian medicines industry. This second article looks at the … Continue reading

Posted in Life Sciences Industry, PBS, Regulatory Services | Tagged , | Comments Off on Dr Greg Pearce – Time to support biosimilars

Using an overseas reference product in your bioequivalence studies

It is the TGA’s preference that bioequivalence (BE) studies to support generic medicines are performed using the Australian (AU) innovator product as the reference; however, within certain TGA conditions, it is possible to use an overseas reference/innovator product in your … Continue reading

Posted in Life Sciences Industry, Regulatory Services, TGA | Tagged , | Comments Off on Using an overseas reference product in your bioequivalence studies

Commercial Eyes welcomes Clare Price

Commercial Eyes is delighted to welcome Clare Price who, this week, takes up the role of Director, Clinical Development.    Clare has a wealth of experience and comes to us from Starpharma.  Clare spent nine years at the nanotech biotechnology company … Continue reading

Posted in Clinical Development, Commercial Eyes | Comments Off on Commercial Eyes welcomes Clare Price

The PBAC major submission deadline is nearly here. Are you prepared for lodgement?

With the March 2016 major submission deadline looming, a significant but commonly overlooked aspect are the key administrative documents that accompany a lodged submission.  With a number of key documents changing, either in new process or content, as well as … Continue reading

Posted in E-Health/Technology, Market Access, PBAC | Tagged , | Comments Off on The PBAC major submission deadline is nearly here. Are you prepared for lodgement?
Copyright © 2014 Commercial Eyes